GLR Partners »

Regeneron Pharmaceuticals shares owned by GLR Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by GLR Partners from 13F filings

Historical chart of GLR Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by GLR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by GLR Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $270k 350 772.64

More positions owned by GLR Partners

Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Series Trust State Street Spd (BIL)
Wisdomtree Tr Us Quality Grow (QGRW)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Spdr Gold Tr Gold Shs (GLD)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYG)
Pacer Fds Tr Trendp Us Lar Cp (PTLC)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Us Aggbd Et (AGG)
Meta Platforms Cl A (META)

View all positions for GLR Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
FMR
Nuveen
Loomis, Sayles and
Invesco
Vanguard Portfolio Management
Goldman Sachs Group
Capital World Investors
Susquehanna International

View all funds holding Regeneron Pharmaceuticals